Wellcome Open Res

Experiences with the Implementation of Cuban Health Cooperation Programs in Low and Middle-Income Countries: A Scoping Review.Njiriri F, Nyanchoka M, Nzinga J, Tsofa B
Wellcome Open Res, (2025). 10:167

Identification of coxsackievirus A24 variant during an acute hemorrhagic conjunctivitis outbreak in coastal Kenya, 2024.Lambisia AW, Mwita Morobe J, Moraa E, Mwarumba S, Korir FKN, Seif Athman R, Kiptui R, Mbee M, Mugo N, Amoth P, Muange P, Houldcroft JC, Barasa E, Mwangangi J, Githinji G, Holmes CE, Ochola-Oyier LI, Agoti CN
Wellcome Open Res, (2025). 10:28

External validation of an admission risk score for predicting inpatient paediatric mortality in two Kenyan public hospitals.Kamau S, Kigo J, Maina M, Gachohi J
Wellcome Open Res, (2024). 9:732

How does Public Financial Management (PFM) influence health system efficiency: A scoping review.Musiega A, Tsofa B, Barasa E
Wellcome Open Res, (2024). 9:566

Examining the development and utilisation of Community-Based Health Information Systems (CBHIS) in Africa: A Scoping Review.Kuvuna B, Nyanchoka M, Guleid F, Ogutu M, Tsofa B, Nzinga J
Wellcome Open Res, (2024). 9:485

Community-Based Health Information Systems in Africa: A Scoping Review of Data Generation, Utilization, and Community Empowerment.Kuvuna B, Nyanchoka M, Guleid F, Ogutu M, Tsofa B, Nzinga J
Wellcome Open Res, (2024). 9:485

A mixed methods study examining the impact of primary health care financing transitions on facility functioning and service delivery in Kenya: a study protocol.Muthuri RNDK, Nzinga J, Tsofa B, Musiega A, Mugo P, Wong E, Mazzilli C, Ng'ang'a W, Hagedorn B, Turner G, Musuva A, Ravishankar N, Murira FM, Barasa E
Wellcome Open Res, (2024). 9:220

A Phase I trial of Non-invasive�Ventilation�and seizure prophylaxis with levetiracetam In�Children with�Cerebral Malaria Trial (NOVICE-M Trial).Maitland K, Obonyo N, Hamaluba M, Ogoda E, Mogaka C, Williams TN, Newton C, Kariuki SM, Gibb DM, Walker AS, Connon R, George EC
Wellcome Open Res, (2024). 9:281

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.Kimotho J, Sein Y, Sayed S, Shah R, Mwai K, Saleh M, Wanjiku P, Mwacharo J, Nyagwange J, Karanja H, Kutima B, Gitonga JN, Mugo D, Karanu A, Moranga L, Oluoch V, Shah J, Mutiso J, Mburu A, Nneka Z, Betti P, Mutinda WU, Issak Abdi A, Bejon P, Ochola-Oyier LI, Warimwe GM, Nduati EW, Ndungu FM
Wellcome Open Res, (2023). 8:350

Assessment of neonatal referral infrastructure and clinical characteristics of referred neonates in three first referral hospitals in Nairobi County, Kenya.Wainaina J, Irimu G, English M, Mbaire E, Waiyego M, Manyasi C, Kimutai D, Emadau C, Muturi C, Aluvaala J
Wellcome Open Res, (2023). 8:126

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).Maitland K, Hamaluba M, Obonyo N, Oguda E, Mogoka C, Williams TN, Chaponda M, Miti S, Kamavu LK, Jonathan Gwasupika J, Connon R, Gibb DM, Dondorp A, Day N, White N, Walker AS, George EC
Wellcome Open Res, (2023). 8:484

Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast.Karisa J, Ominde K, Tuwei M, Bartilol B, Ondieki Z, Musani H, Wanjiku C, Mwikali K, Babu L, Rono M, Eminov M, Mbogo C, Bejon P, Mwangangi J, Laroche M, Maia M
Wellcome Open Res, (2023). 8:151

Safety and immunogenicity of varied doses of R21/Matrix-M� vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.Sang S, Datoo MS, Otieno E, Muiruri C, Bellamy D, Gathuri E, Ngoto O, Musembi J, Provstgaard-Morys S, Stockdale L, Aboagye J, Woods D, Lawrie A, Roberts R, Keter K, Kimani D, Ndungu F, Kapulu M, Njau I, Orindi B, Ewer KJ, Hill AVS, Bejon P, Hamaluba M
Wellcome Open Res, (2023). 8:450

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M, Sang S, Orindi B, Njau I, Karanja H, Kamau N, Gitonga JN, Mugo D, Wright D, Nyagwange J, Kutima B, Omuoyo D, Mwatasa M, Ngetsa C, Agoti C, Cheruiyot S, Nyaguara A, Munene M, Mturi N, Oloo E, Ochola-Oyier L, Mumba N, Mauncho C, Namayi R, Davies A, Tsofa B, Nduati EW, Aliyan N, Kasera K, Etyang A, Boyd A, Hill A, Gilbert S, Douglas A, Pollard A, Bejon P, Lambe T, Warimwe G
Wellcome Open Res, (2023). 8:182

Mortality among non-severely under nourished children with pneumonia globally: protocol for a systematic review and meta-analysis.Nalwanga D, Bakker C, Kiggwe A, Negash AA, Ocan M, Briend A, Maitland K, Musiiime V, Karamagi C
Wellcome Open Res, (2023). 8:551

Ethical issues of involving people with intellectual disabilities in genomic research: a scoping review protocol.Chepkirui D, Kipkemoi P, Bitta M, Harris E, Musesengwa R, Kamuya D
Wellcome Open Res, (2023). 8:340

Universal iron supplementation: the best strategy to tackle childhood anaemia in malaria-endemic countries?.Karthikappallil R, Atkinson SH
Wellcome Open Res, (2023). 8:345

A rapid review of community engagement and informed consent processes for adaptive platform trials and alternative design trials for public health emergencies.Davies A, Ormel I, Bernier A, Harriss E, Mumba N, Gobat N, Schwartz L, Cheah PY
Wellcome Open Res, (2023). 8:194

Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections.Abuga KM, Nairz M, MacLennan CA, Atkinson SH
Wellcome Open Res, (2023). 8:48

Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries.Nyiro JU, Nyawanda BO, Bukusi E, Mureithi MW, Murunga N, Nokes DJ, Bigogo G, Otieno NA, Opere VA, Ouma A, Pecenka C, Munywoki PK
Wellcome Open Res, (2023). 8:154